Mirai-MRI: Validation of AI Models for Breast Cancer Risk
Mirai-MRI: Multi-site Prospective Validation of AI Models for Breast Cancer Risk
University of California, San Francisco
400 participants
Nov 3, 2025
INTERVENTIONAL
Conditions
Summary
This is a multi-center, single arm trial to evaluate the cancer detection rate of supplemental screening magnetic resonance imaging (MRI) in participants who are high-risk by Mirai-MRI assessment. Mirai is an accurate cancer risk model based on full-resolution mammograms.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Undergo Magnetic resonance (MR) imaging
AI applied to MRI images
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07121972